Responses
Immunotherapy biomarkers
Original research
NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.